基于超声技术的非酒精性脂肪性肝病肝脏脂肪定量:文献综述及其诊断性能
本文综述了基于超声的定量技术在非酒精性脂肪性肝病肝脏脂肪定量中的诊断性能。非酒精性脂肪性肝病以肝脏脂肪含量>5%为特征,影响全球超过十亿人,可进展为肝硬化和死亡。肝活检是当前检测肝脂肪变性的参考标准,但存在潜在并发症,因此非侵入性影像生物标志物得到广泛研究。基于磁共振成像的方法已被证明在定量肝脏脂肪变性方面准确,但成本高且可用性有限。基于超声的定量成像技术因广泛可用、易用且相对成本效益高而日益被采用。本文重点介绍定量超声方法及其在非酒精性脂肪性肝病领域的诊断性能。
要点
- 超声定量技术因广泛可用、易用且相对成本效益高而日益用于肝脏脂肪定量。
- 肝活检是检测肝脂肪变性的当前参考标准,但存在潜在并发症。
- 基于磁共振成像的方法已被证明在定量肝脏脂肪变性方面准确,但成本高且可用性有限。
核心结论
- 本综述聚焦于定量超声方法及其在非酒精性脂肪性肝病领域的诊断性能。
研究设计与样本
- 文献综述,检索范围与纳入文献数原文未报告。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Non-alcoholic fatty liver disease is a condition that is characterized by the presence of >5% fat in the liver and affects more than one billion people worldwide. If adequate and early precautions are not taken, non-alcoholic fatty liver disease can progress to cirrhosis and death. The current reference standard for detecting hepatic steatosis is a liver biopsy. However, because of the potential morbidity associated with liver biopsies, non-invasive imaging biomarkers have been extensively investigated. Magnetic resonance imaging-based methods have proven accuracy in quantifying liver steatosis; however, these techniques are costly and have limited availability. Ultrasound-based quantitative imaging techniques are increasingly utilized because of their widespread availability, ease of use and relative cost-effectiveness. Several ultrasound-based liver fat quantification techniques have been investigated, including techniques that measure changes in the acoustic properties of the liver caused by the presence of fat. In this review, we focus on quantitative ultrasound approaches and their diagnostic performance in the realm of non-alcoholic fatty liver disease.
引用
- Ozturk A, Grajo JR, Gee MS, et al. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. Ultrasound Med Biol. 2018. PMID: 30232020. doi:10.1016/j.ultrasmedbio.2018.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。